Last reviewed · How we verify
Fluorouracil, leucovorin, oxaliplatin, docetaxel
Fluorouracil, leucovorin, oxaliplatin, docetaxel is a Small molecule drug developed by AIO-Studien-gGmbH. It is currently in Phase 2 development. Also known as: FLOT.
At a glance
| Generic name | Fluorouracil, leucovorin, oxaliplatin, docetaxel |
|---|---|
| Also known as | FLOT |
| Sponsor | AIO-Studien-gGmbH |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
- Nausea
- Anaemia
- Neutrophil count decreased
- Decreased appetite
- Diarrhoea
- Vomiting
- Weight decreased
- Constipation
- Neutropenia
- White blood cell count decreased
- Fatigue
- Asthenia
Key clinical trials
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma (PHASE2)
- Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) (PHASE1)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) (PHASE3)
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension (PHASE3)
- Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (PHASE2, PHASE3)
- A Study of ASP3082 in Adults With Advanced Solid Tumors (PHASE1)
- A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors (PHASE1, PHASE2)
- Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluorouracil, leucovorin, oxaliplatin, docetaxel CI brief — competitive landscape report
- Fluorouracil, leucovorin, oxaliplatin, docetaxel updates RSS · CI watch RSS
- AIO-Studien-gGmbH portfolio CI
Frequently asked questions about Fluorouracil, leucovorin, oxaliplatin, docetaxel
What is Fluorouracil, leucovorin, oxaliplatin, docetaxel?
Fluorouracil, leucovorin, oxaliplatin, docetaxel is a Small molecule drug developed by AIO-Studien-gGmbH.
Who makes Fluorouracil, leucovorin, oxaliplatin, docetaxel?
Fluorouracil, leucovorin, oxaliplatin, docetaxel is developed by AIO-Studien-gGmbH (see full AIO-Studien-gGmbH pipeline at /company/aio-studien-ggmbh).
Is Fluorouracil, leucovorin, oxaliplatin, docetaxel also known as anything else?
Fluorouracil, leucovorin, oxaliplatin, docetaxel is also known as FLOT.
What development phase is Fluorouracil, leucovorin, oxaliplatin, docetaxel in?
Fluorouracil, leucovorin, oxaliplatin, docetaxel is in Phase 2.
What are the side effects of Fluorouracil, leucovorin, oxaliplatin, docetaxel?
Common side effects of Fluorouracil, leucovorin, oxaliplatin, docetaxel include Nausea, Anaemia, Neutrophil count decreased, Decreased appetite, Diarrhoea, Vomiting.
Related
- Manufacturer: AIO-Studien-gGmbH — full pipeline
- Also known as: FLOT
- Compare: Fluorouracil, leucovorin, oxaliplatin, docetaxel vs similar drugs
- Pricing: Fluorouracil, leucovorin, oxaliplatin, docetaxel cost, discount & access